Predictors of relapse in Takayasu arteritis

医学 内科学 血管炎 比例危险模型 动脉炎 队列 前瞻性队列研究 巨细胞动脉炎 心脏病学 胃肠病学 疾病
作者
Shiping He,Ruofan Li,Shangyi Jin,Yanhong Wang,Hongbin Li,Xinwang Duan,Lili Pan,Lijun Wu,Yongfu Wang,Yan Zhang,Zhenbiao Wu,Jing Li,Yunjiao Yang,Xinping Tian,Xiaofeng Zeng
出处
期刊:European Journal of Internal Medicine [Elsevier BV]
标识
DOI:10.1016/j.ejim.2023.02.027
摘要

Takayasu arteritis (TAK) is a large-vessel vasculitis with high relapse rate. Longitudinal studies identifying risk factors of relapse are limited. We aimed to analyze the associated factors and develop a risk prediction model for relapse.We analyzed the associated factors for relapse in a prospective cohort of 549 TAK patients from the Chinese Registry of Systemic Vasculitis cohort between June 2014 and December 2021 using univariate and multivariate Cox regression analyses. We also developed a prediction model for relapse, and stratified patients into low-, medium-, and high-risk groups. Discrimination and calibration were measured using C-index and calibration plots.At a median follow-up of 44 (IQR 26-62) months, 276 (50.3%) patients experienced relapses. History of relapse (HR 2.78 [2.14-3.60]), disease duration <24 months (HR 1.78 [1.37-2.32]), history of cerebrovascular events (HR 1.55 [1.12-2.16]), aneurysm (HR 1.49 [1.10-2.04], ascending aorta or aortic arch involvement (HR 1.37 [1.05-1.79]), elevated high-sensitivity C-reactive protein level (HR 1.34 [1.03-1.73]), elevated white blood cell count (HR 1.32 [1.03-1.69]), and the number of involved arteries ≥6 (HR 1.31 [1.00-1.72]) at baseline independently increased the risk of relapse and were included in the prediction model. The C-index of the prediction model was 0.70 (95% CI 0.67-0.74). Predictions correlated with observed outcomes on the calibration plots. Compared to the low-risk group, both medium and high-risk groups had a significantly higher relapse risk.Disease relapse is common in TAK patients. This prediction model may help to identify high-risk patients for relapse and assist clinical decision-making.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
2秒前
2秒前
3秒前
英俊的铭应助郭鑫采纳,获得10
3秒前
3秒前
3秒前
难过的敏发布了新的文献求助10
3秒前
4秒前
qq完成签到,获得积分10
4秒前
郭生发布了新的文献求助10
4秒前
4秒前
adeno发布了新的文献求助10
4秒前
庞贝完成签到,获得积分10
4秒前
晚舟寒发布了新的文献求助10
4秒前
晚舟寒发布了新的文献求助10
4秒前
巫雍完成签到,获得积分10
4秒前
艺心完成签到 ,获得积分10
5秒前
xinL完成签到,获得积分10
6秒前
123qwe发布了新的文献求助10
6秒前
6秒前
Clxzzgzg发布了新的文献求助10
7秒前
Whim应助秋天的秋采纳,获得30
7秒前
SSSSCCCCIIII发布了新的文献求助10
7秒前
甘博发布了新的文献求助10
7秒前
树L发布了新的文献求助10
8秒前
JiangY发布了新的文献求助10
8秒前
AS_LYN发布了新的文献求助10
8秒前
火星上的万天完成签到,获得积分10
8秒前
研ZZ发布了新的文献求助10
9秒前
酷波er应助小璇儿采纳,获得10
9秒前
lya发布了新的文献求助10
9秒前
留溪月完成签到,获得积分10
9秒前
rabpig应助TT采纳,获得10
9秒前
adeno完成签到,获得积分10
10秒前
钱学森发布了新的文献求助10
11秒前
董ddd完成签到,获得积分20
11秒前
超帅的白易完成签到 ,获得积分10
11秒前
浅池星完成签到 ,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Burger's Medicinal Chemistry, Drug Discovery and Development, Volumes 1 - 8, 8 Volume Set, 8th Edition 1800
Cronologia da história de Macau 1600
Netter collection Volume 9 Part I upper digestive tract及Part III Liver Biliary Pancreas 3rd 2024 的超高清PDF,大小约几百兆,不是几十兆版本的 1050
Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents 1000
Research Handbook on the Law of the Sea 1000
Contemporary Debates in Epistemology (3rd Edition) 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6168947
求助须知:如何正确求助?哪些是违规求助? 7996533
关于积分的说明 16631402
捐赠科研通 5274090
什么是DOI,文献DOI怎么找? 2813603
邀请新用户注册赠送积分活动 1793346
关于科研通互助平台的介绍 1659279